Key Market Indicators
The prevalence of HIV/AIDS in Burkina Faso is projected to drop by 9.4% on average each year through 2026. This will lead to a total decrease of 8.6% since 1995. In 2021, Burkina Faso was ranked 20th, with 14,690 people aged 0-14 living with the virus. Indonesia had the highest rate, with Nigeria, Mozambique and Tanzania taking the second, third and fourth spots respectively. The country’s HIV/AIDS treatment coverage is also set to increase, going from 75% in 2021 to 91% in 2026. That’s an average growth of 3.1% each year since 2008. South Africa had the highest rate in 2021, with Cape Verde, Latvia and Zimbabwe following in second, third and fourth place.
Burkina Faso HIV AIDS Market Data and Forecasts
How much will Burkina Faso HIV AIDS Market grow to 2026?
More in HIV AIDS Industry for 2028Improve your Knowledge with the latest Indicators and Trends
-
HIV Treatment Sector: Comprehensive Analysis of Therapeutic Advancements and Opportunities
The modern HIV treatment landscape has been remodelled by the introduction of revolutionary drugs and therapeutic interventions focusing on improved patient compliance and reduced side effects. Antiretroviral therapy (ART) has notably evolved, with a surge of new drug categories, such as integrase inhibitors, showing remarkable efficacy. There has also been...
Discover more insights -
HIV Market Access Impact: Influential Points & Comprehensive Perspectives
The influence within the HIV market is primarily driven by multiple factors. Key among them includes the level of pharmaceutical innovation, the prevalence of the disease, and the nature of funding for treatment and research. Pharmaceutical companies have been more amicable towards investing in the development of groundbreaking treatments, paving...
Discover more insights